These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4780002)

  • 21. Porphyria cutanea tarda in an 8-year-old boy.
    Welland FH; Carlsen RA
    Arch Dermatol; 1969 Apr; 99(4):451-4. PubMed ID: 5769329
    [No Abstract]   [Full Text] [Related]  

  • 22. [Porphyria cutanea tarda].
    Velde KT; Noordhoek KH
    Ned Tijdschr Geneeskd; 1976 May; 120(22):952-7. PubMed ID: 1272435
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda].
    Broese I; Mattheus A
    Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437
    [No Abstract]   [Full Text] [Related]  

  • 24. Phlebotomy treatment in porphyria cutanea tarda combined with beta-thalassaemia.
    Adjarov D; Donov M; Ivanov E; Naidenova E
    Dermatologica; 1984; 169(4):184-7. PubMed ID: 6500120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphology of liver damage in chronic hepatic porphyria with special reference to the effect of therapy].
    Riedel H; Justus J; Köstler E; Pätzold K; Kemmer C
    Pathologe; 1984 Jul; 5(4):216-25. PubMed ID: 6091088
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effectivity of long-term treatment of porphyria cutanea tarda from a hepatological viewpoint].
    Höfs T; Kleine FD; Grüngreiff K; Kleine S; Fiedler J
    Z Gesamte Inn Med; 1978 Jun; 33(12):410-3. PubMed ID: 685336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porphyria cutanea tarda treated by repeated venesection: clinical and biochemical response.
    Baker H; Turnbull A
    Proc R Soc Med; 1969 Jun; 62(6):590-2. PubMed ID: 5802737
    [No Abstract]   [Full Text] [Related]  

  • 28. [Catamnestic studies in porphyria cutanea tarda with special reference to therapy].
    Barth J; Petter O
    Z Gesamte Inn Med; 1971 Jan; 26(2):66-74. PubMed ID: 5560767
    [No Abstract]   [Full Text] [Related]  

  • 29. [A summary of twelve-year experience on the therapy of porphyria cutanea tarda (author's transl)].
    Resl V
    Cesk Dermatol; 1978; 53(5):336-43. PubMed ID: 729018
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of the porphyrias].
    Horie Y; Okano J; Kitaoka S; Tajima F; Kawasaki H
    Nihon Rinsho; 1995 Jun; 53(6):1456-62. PubMed ID: 7542353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Serum-haemopexin concentration in porphyria cutanea tarda (author's transl)].
    Meiers HG; Mawlawi H; Lissner R; Ippen H
    Dtsch Med Wochenschr; 1973 Nov; 98(47):2243-6. PubMed ID: 4759520
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current therapeutic methods in porphyria cutanea tarda].
    Giannotti B
    G Ital Dermatol Venereol; 1984; 119(3):167-9. PubMed ID: 6746011
    [No Abstract]   [Full Text] [Related]  

  • 33. [Repeated venesection in pseudoporphyria cutanea tarda of hemodialysis (author's transl)].
    Pecchini F; Emanuelli C; Gruttad'auria C; Orlandini G
    Ateneo Parmense Acta Biomed; 1980; 51(5):439-43. PubMed ID: 7225151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chloroquine therapy in porphyria cutanea tarda].
    Snitker G
    Ugeskr Laeger; 1971 Aug; 133(33):1605-10. PubMed ID: 5099470
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)].
    Leonhardi G; Klähn KH; Gürenci J
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):43-6. PubMed ID: 401939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ON A CASE OF PORPHYRIA CUTANEA TARDA WITH SPECIAL REFERENCE TO ITS THERAPY].
    GRUENER F
    Wien Klin Wochenschr; 1963 Oct; 75():701-3. PubMed ID: 14093586
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of phlebotomy therapy in porphyria cutanea tarda. Its relation to the phlebotomy-induced reduction of iron stores.
    Lundvall O
    Acta Med Scand; 1971; 189(1-2):33-49. PubMed ID: 5121531
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda.
    Cainelli T; Di Padova C; Marchesi L; Gori G; Rovagnati P; Podenzani SA; Bessone E; Cantoni L
    Br J Dermatol; 1983 May; 108(5):593-600. PubMed ID: 6849826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunochemical parameters and blood-letting therapy in porphyria cutanea tarda (author's transl)].
    Schwartze G; Kühn G
    Dermatol Monatsschr; 1980 Jan; 166(1):19-23. PubMed ID: 7398963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.